Koyfin Home > Directory > Health Care > Amedisys Inc > Capital Expenditures

Amedisys Inc Capital Expenditures Chart (AMED)

Amedisys Inc annual/quarterly Capital Expenditures from 2010 to 2020.
  • Amedisys Inc Capital Expenditures for the quarter ending June 06, 2020 was $0m a -1,264.79% increase of 3m year over year
  • Amedisys Inc Capital Expenditures for the last 12 months ending June 06, 2020 was $-7m a -4.57% increase of 0m year over year
  • Amedisys Inc Annual Capital Expenditures for 2019 was $-8m a 16.86% decrease of -1m from 2018
  • Amedisys Inc Annual Capital Expenditures for 2018 was $-7m a -63.27% increase of 4m from 2017
  • Amedisys Inc Annual Capital Expenditures for 2017 was $-11m a -46.79% increase of 5m from 2016
Other Cash Flow Metrics:
  • Amedisys Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $64m a 37.04% increase of 24m year over year
  • Amedisys Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $47m a 41.63% increase of 20m year over year
  • Amedisys Inc Total Revenue for the quarter ending December 12, 2018 was $434m a 8.08% increase of 35m year over year
View Chart On Koyfin

Quarterly AMED Capital Expenditures Data

06/2020$0m
03/2020$-1m
12/2019$-2m
09/2019$-4m
06/2019$-1m
03/2019$-1m
12/2018$-1m
09/2018$-4m
06/2018$0m
03/2018$-1m

Annual AMED Capital Expenditures Data

2019$-8m
2018$-7m
2017$-11m
2016$-16m
2015$-21m
2014$-12m
2013$-42m
2012$-48m
2011$-44m
2010$-64m